News

/
/
Page 10
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome

London, UK; 26 Sept 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: “GWP,” “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing…

Your Feedback Requested: Parents/Caregivers Medical Cannabis Survey

At the Child Neurology Foundation (CNF), our mission is to serve as a collaborative center of education and support for children living with neurologic conditions…

PCORI Annual Meeting Scholarships

The 2016 PCORI Annual Meeting is taking place in November in the greater Washington, D.C. area, and we’re offering scholarships to help patients, caregivers, and…

The Arc of Illinois Stipend Funds to Attend Conferences Related to Developmental Disability Issues

Consumer Stipend Funds The Arc of Illinois, through a grant from the Illinois Council on Developmental Disabilities, administers the Consumer Involvement Program and distributes consumer stipend…

The First Annual Luke G Neurological Scholarship from Bella Soul

Requirements for Scholarship: Must be a college student living with a neurological disorder. Must be enrolled as full time student. The limitations are not bound…

Ipsen Biopharmaceuticals, Inc. announces FDA approval of Dysport® (abobotulinumtoxinA) for the treatment of lower limb spasticity in pediatric patients aged two and older

First and only FDA-approved botulinum toxin for the treatment of pediatric lower limb spasticity and studied in patients with cerebral palsy Pivotal study in cerebral…

New Recommendations for Transitioning Youths with Brain Disorders to Adult Care

The Child Neurology Foundation (CNF) is pleased to announce the publication of a new consensus statement endorsed by the American Academy of Neurology (AAN), Child Neurology…

Enroll for Epilepsy Genetics Initiative today! Two new enrollment partners added

Enroll for Epilepsy Genetics Initiative today! Two new enrollment partners added EGI continues building upon the promise to tirelessly search for new ways of understanding the…

GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome

– Primary endpoint achieved with high statistical significance (p=0.0135) showing that Epidiolex treatment reduces drop seizures compared to placebo – – Today’s LGS data follows…

FYCOMPA® (perampanel) Oral Suspension Now Available as an Option for Patients with Epilepsy Who May Have Difficulty Swallowing Tablets or Prefer Liquids

Eisai Inc. announced today the availability of FYCOMPA® (perampanel) Oral Suspension, a new bioequivalent interchangeable alternative to the FYCOMPA tablet for patients who have difficulty…

ANNOUNCING New CURE Program: Post-Traumatic Epilepsy Initiative

In collaboration with the U.S. Department of Defense, CURE is excited to launch a NEW research program to support a collaborative, milestone-driven approach to advance…

Partners Against Mortality in Epilepsy Conference

DATES: Thursday June 23 – Sunday, June 26 LOCATION: The Westin Alexandria, 400 Courthouse Square, Alexandria, VA 22314 CLOSEST AIRPORT: Reagan National (4.5 miles from…

Help Us Improve our Website: Parent, Caregiver, and Advocate Survey

In preparation for the upcoming Child Neurology Foundation (CNF) Board of Directors’ strategic planning meeting, we kindly request a few minutes of your time to complete…

The Epilepsy Foundation: Knowledge about Epilepsy and Risk Factors Survey

The Epilepsy Foundation is constantly enhancing epilepsy.com. To help, they are asking users for a better understanding of what they know about the impact of…

The Epilepsy Foundation SUDEP Institute will be awarding more than $1 million to address Sudden Unexpected Death in Epilepsy (SUDEP)

The Epilepsy Foundation SUDEP Institute will be awarding more than $1 million for a series of four prize challenge competitions working to address Sudden Unexpected…

UMDF Great Lakes Regional Mitochondrial Medicine Symposium

Clinical/Medical Sessions (CME) Friday, May 20, 2016 Patient/Family Sessions (non CME) Saturday, May 21, 2016 To view schedule and speakers – visit www.umdf.org/GreatLakesClinicalAgenda. Complete symposium…

May is Stroke Awareness Month: “I didn’t know a child could have a stroke!”

When people think of a stroke, a child is not the first image that comes to mind. The International Alliance for Pediatric Stroke aims to…

Eisai Announces FDA Approval of FYCOMPA® (perampanel) Oral Suspension for Adjunctive Therapy in the Treatment of Partial-Onset Seizures and Primary Generalized Tonic-Clonic Seizures

New Formulation Expands Treatment Options for Epilepsy Patients with POS and PGTC Seizures Woodcliff Lake, NJ, May 2, 2016 – Eisai Inc. today announced that…

Eisai Launches Latest Book in Comic Book Series:  “Medikidz Explain Playing Sports With Epilepsy”

Living with epilepsy can be challenging, and even scary at times, but it doesn’t have to stop you from pursuing your dreams. With the help…

CURE: NOW ACCEPTING 2017 Seminar Series Applications!

Host a 2017 CURE Seminar At Your Institution CURE is now accepting applications for the 2017 Frontiers in Research Seminar Series! Approximately 10 seminars will be…

Start typing and press Enter to search

Shopping Cart